Y
Yuling Liu
Researcher at Peking Union Medical College
Publications - 86
Citations - 1191
Yuling Liu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 17, co-authored 49 publications receiving 802 citations. Previous affiliations of Yuling Liu include University of Macau.
Papers
More filters
Journal ArticleDOI
Transdermal delivery of insulin using microneedle rollers in vivo
TL;DR: In conclusion, microneedle rollers with 500-microm or shorter lengths are safe and useful in transdermal delivery of insulin in vivo and are related to the recovery of skin barrier function and agrees well with EB results.
Journal ArticleDOI
Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study
TL;DR: This study quantitatively estimate the mortality, morbidity, and analyze the trends of 29 cancer groups in 195 countries/regions between 1990 and 2017 to provide basis for future investigations to the common etiological factors, leading to the occurrence of different cancers.
Journal ArticleDOI
The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017.
TL;DR: The global incidence of liver cancer is still rising and the causes have national, regional, or population specificities, so more targeted prevention strategies must be developed for the different etiologic types in order to reduce liver cancer burden.
Journal ArticleDOI
Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation
TL;DR: With the aid of phospholipid-complexation techniques, some hydrophilic peptides, such as insulin, can be successfully entrapped into L/C NPs, which could improve oral bioavailability, time-dependent release, and therapeutic activity.
Journal ArticleDOI
Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
TL;DR: Findings suggest that co-delivery of PTX and BA in nanoemulsions might provide a potential combined therapeutic strategy for overcoming MDR in breast cancer.